-+ 0.00%
-+ 0.00%
-+ 0.00%
GeoVax Labs Names Anna Skowron Interim CFO
Share
Listen to the news
GeoVax Labs Names Anna Skowron Interim CFO
  • GeoVax Labs appointed Anna Skowron interim chief financial officer effective November 16, 2026, on a fractional basis.
  • Skowron has been a director at BPC Consulting since September 2025, providing financial leadership, accounting and reporting services.
  • Mark W. Reynolds resigned as chief financial officer and corporate secretary effective November 13, 2026.
  • Chief Medical Officer Kelly T. McKee was terminated effective immediately on November 17, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-037764), on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending